Particles, compositions, and methods for ophthalmic and/or other applications
CN111465601A
RET9 and VEGFR2 inhibitors
WO2018053321A1
Particles, compositions, and methods for ophthalmic and/or other applications
CA3037174A1
Particles, compositions, and methods for ophthalmic and/or other applications
WO2019055028A1
Particles, compositions, and methods for ophthalmic and/or other applications
US2018065978A1
Crystalline forms of therapeutic compounds and uses thereof
WO2018048746A1
Crystalline forms of therapeutic compounds and uses thereof
AU2017324716A1
Crystalline forms of therapeutic compounds and uses thereof
US2017260193A1
Crystalline forms of therapeutic compounds and uses thereof
CA2969467A1
1-amino-triazolo(1,5-a)pyridine-substituted urea derivative and uses thereof
US2017313724A1
Crystalline forms of a therapeutic compound and uses thereof
EP3062795A1
Crystalline forms of therapeutic compounds and uses thereof
US2016257693A1
Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof
MX2016005668A
CRYSTALLINE FORMS OF THERAPEUTIC COMPOUNDS and USES THEREOF.
